SynthesisThe Cochrane database of systematic reviews2008
Nebulized hypertonic saline solution for acute bronchiolitis in infants.
Synthesis in The Cochrane database of systematic reviews, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 32 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized Controlled Trial to Evaluate Efficacy of Nebulized Hypertonic Saline vs. Normal Saline in the Treatment of Hospitalized Children With Bronchiolitis
Nebulized Hypertonic Saline for Acute Bronchiolitis in the Emergency Department
Nebulized Hypertonic Saline for Mechanically Ventilated Children
A Randomized Controlled Trial of Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis
Who cites it
32 citing papers in PubMed, 5 syntheses or guidelines pooled it, 207 citations in OpenAlex.
- Nebulised hypertonic saline solution for acute bronchiolitis in infants.The Cochrane database of systematic reviews · 2017Pooled it
- Hypertonic saline (HS) for acute bronchiolitis: Systematic review and meta-analysis.BMC pulmonary medicine · 2015Pooled it
- Glucocorticoids for acute viral bronchiolitis in infants and young children.The Cochrane database of systematic reviews · 2013Pooled it
- Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months.The Cochrane database of systematic reviews · 2012Pooled it
- Epinephrine for bronchiolitis.The Cochrane database of systematic reviews · 2011Pooled it
- Trial
- The Role of Seawater and Saline Solutions in Treatment of Upper Respiratory Conditions.Marine drugs · 2022Review
- Improving Evidence Based Bronchiolitis Care.Clinical pediatric emergency medicine · 2018Article
- Maybe there is no such thing as bronchiolitis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016Review
- Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2016Article
- [Respiratory emergencies and airway management in children].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2015Review
- Mucolytics for intubated asthmatic children: a national survey of United kingdom paediatric intensive care consultants.Critical care research and practice · 2015Article
- Therapeutic effects of Ventolin versus hypertonic saline 3% for acute bronchiolitis in children.Medical journal of the Islamic Republic of Iran · 2015Article
- Continuous positive airway pressure for bronchiolitis in a general paediatric ward; a feasibility study.BMC pediatrics · 2014Article
- Viral bronchiolitis in children: a common condition with few therapeutic options.Early human development · 2013Review
- Recent advances in management of bronchiolitis.Indian pediatrics · 2013Review
- Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease.American journal of respiratory cell and molecular biology · 2013Article
- Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13.Critical care medicine · 2012Article
- Impact of a bronchiolitis clinical care pathway on treatment and hospital stay.European journal of pediatrics · 2012Article
- Common pediatric respiratory emergencies.Emergency medicine clinics of North America · 2012Review
Corrections and comments
- Commented on by
- Updated by
Authors and funding
4 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAirway edema and mucus plugging are the predominant pathological features in infants with acute viral bronchiolitis. Nebulized hypertonic saline solution may reduce these pathological changes and decrease airway obstruction.
objectivesTo assess the effects of nebulized hypertonic saline solution in infants with acute viral bronchiolitis. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2007, issue 4), which contains the Cochrane Acute Respiratory Infections Group Specialized Register; OLDMEDLINE (1951 to 1965); MEDLINE (1966 to November 2007); EMBASE (1974 to November 2007); and LILACS (November 2007). SELECTION CRITERIA: Randomised controlled trials (RCTs) and quasi-RCTs using nebulized hypertonic saline alone or in conjunction with bronchodilators as an active intervention in infants up to 24 months of age with acute bronchiolitis. DATA COLLECTION AND ANALYSIS: Two review authors (ZL, MRA) independently performed data extraction and study quality assessment. We pooled the data from individual trials using the Cochrane statistical package Review Manager (RevMan). MAIN
resultsWe included four trials involving 254 infants with acute viral bronchiolitis (189 inpatients and 65 outpatients) in this review. Patients treated with nebulized 3% saline had a significantly shorter mean length of hospital stay compared to those treated with nebulized 0.9% saline (mean difference (MD) -0.94 days, 95% CI -1.48 to -0.40, P = 0.0006). The 3% saline group also had a significantly lower post-inhalation clinical score than the 0.9% saline group in the first three days of treatment (day 1: MD -0.75, 95% CI -1.38 to -0.12, P = 0.02; day 2: MD -1.18, 95% CI -1.97 to -0.39, P = 0.003; day 3: MD -1.28, 95% CI -2.57 to 0.00, P = 0.05). The effect of nebulized hypertonic saline in improving clinical score was greater among outpatients than inpatients. No adverse events related to 3% saline inhalation were reported. AUTHORS'
conclusionsCurrent evidence suggests nebulized 3% saline may significantly reduce the length of hospital stay and improve the clinical severity score in infants with acute viral bronchiolitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.